The emergence of bacteria that co-express serine- and metallo- carbapenemases is a threat to the efficacy of the available -lactam antibiotic armamentarium. The 4-amino-1,2,4-triazole-3-thione scaffold has been selected as the starting chemical moiety in the design of a small library of -Lactamase inhibitors (BLIs) with extended activity profiles. The synthesised compounds have been validated in vitro against class A serine Lactamase (SBLs) KPC-2 and class B1 metallo Lactamases (MBLs) VIM-1 and IMP-1. Of the synthesised derivatives, four compounds showed cross-class micromolar inhibition potency and therefore underwent analyses to elucidate their binding mode within the catalytic pockets of serine- and metallo-BLs. Moreover, several members of the synthesised library have been evaluated, in combination with meropenem (MEM), against clinical strains that overexpress BLs for their ability to synergise carbapenems.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151704PMC
http://dx.doi.org/10.3390/ph13030052DOI Listing

Publication Analysis

Top Keywords

4-amino-124-triazole-3-thione promising
4
promising scaffold
4
scaffold inhibition
4
inhibition serine
4
serine metallo--lactamases
4
metallo--lactamases emergence
4
emergence bacteria
4
bacteria co-express
4
co-express serine-
4
serine- metallo-
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!